Shares of athenahealth (NASDAQ:ATHN) are down 18% as of 11:32 a.m. EDT following the release of the company's first-quarter earnings report after the bell yesterday.
Superficially, the quarter wasn't that bad for the healthcare technology specialist; revenue grew 11.4% year over year.
Many companies would gladly take double-digit revenue growth, but when shareholders are used to growth in the 20% range, 11% growth feels like a losing quarter, and investors are going to adjust their valuations accordingly.
The use of athenaOne by hospitals and Athenahealth's population health products are still going strong, with growth of 88% and 25% quarter over quarter, respectively. The slowdown in growth came from its athenaOne product used in the ambulatory setting, which grew by 2% to 6% quarter over quarter for the different healthcare providers the company tracks.
Despite the increase in revenue, adjusted earnings dropped to $0.32 per share from $0.34 per share in the year-ago quarter, although a lot of that had to do with research and development costs increasing more than 41% year over year, which will hopefully boost sales with better products in future quarters.
The slower growth caused management to lower its full-year 2017 guidance. Athenahealth now expects 2017 revenue in the range of $1.21 billion to $1.25 billion, down from the previous guidance of $1.29 billion to $1.33 billion.
Earnings guidance was also adjusted down, with an expectation for 2017 GAAP operating income between $36 million and $46 million, down substantially from previous guidance in the range of $61 million to $81 million.
More from The Motley Fool
Why Atlassian, Dover, and athenahealth Jumped Today
These stocks helped lead Wall Street higher. Find out why.
Why Athenahealth Is Soaring Today
News that layoffs are underway overshadowed mixed earnings results.
Athenahealth, Inc. Cuts Financial Outlook and 9% of Its Workforce
Despite increasing revenue in the third quarter, the cloud-based healthcare technology company faces some serious headwinds.